For a carbon-neutral bioeconomy, processes are needed that can efficiently capture CO2 and convert it into valuable products.

A research team at Leibniz-HKI describes a new enzyme in the journal Angewandte Chemie International Edition that renders the ...

Burkholderia pseudomallei is considered one of the most dangerous bacterial pathogens in the tropics. The disease melioidosis, caused by these ...

In a breakthrough that defies nature, Northwestern University and Stanford University synthetic biologists have created a new ...

University of California San Diego researchers have discovered the enzyme responsible for chromothripsis, a process in which a single chromosome is shattered into pieces and rearranged in a scrambled ...

The proposed designs were then synthesised and tested in the lab where they achieved enzymatic activities close to those found in nature. ‘They’re not the best enzymes that have ever existed in nature ...

Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Metabolic dysfunction-associated steatotic liver disease (MASLD), a spectrum of liver conditions ranging from simple steatosis to steatohepatitis ...

Get the latest Moderna (MRNA) stock analysis: balanced risk-reward, new vaccine launches, and pipeline insights. See why we ...

Natural biological systems cannot efficiently convert waste CO₂ or its derivatives into useful building-block chemicals at a scale that can keep pace with rising atmospheric carbon. Engineer a fully ...